Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed May 9, 2013 · 10-Q · 39 days after period end · 0001193125-13-210982
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | — | $114.00K | — |
| Net Income | -$1.88M | -$1.89M | -$863.00K |
| EPS Diluted | -$0.97 | -$1.44 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 9, 2013 · 39 d after period end
